English

CYTOGENIX INC

EDGAR

Quarterly report (10-Q) · filed 2009-05-20

50 filing records in this dataset, filed from 1999-11-16 to 2009-05-20. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2009-03-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-88.5 thousand USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -88498 USD Source

Free cash flow

-88.5 thousand USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -88498 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 82.9 thousand USD 2009-03-31 Source
Exact value

82927 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

39.2 thousand USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Revenue: 15188 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 0 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 52348 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 28348 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 0 USD · 2009-01-01 – 2009-03-31 Source

Net income

-2.71 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Net income: -1114061 USD · 2008-04-01 – 2008-06-30 Source
Net income: -640135 USD · 2008-07-01 – 2008-09-30 Source
Net income: -3388623 USD · 2008-01-01 – 2008-12-31 Source
Net income: -2637451 USD · 2008-01-01 – 2008-09-30 Source
Net income: -203193 USD · 2009-01-01 – 2009-03-31 Source

Capital expenditure

0 USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-05-20.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2008-12-31
Operating income: 8 of 11 periods available· newest 2008-12-31
Net income: 11 of 11 periods available· newest 2008-12-31
Operating cash flow: 10 of 11 periods available· newest 2006-12-31
Capital expenditure: 9 of 11 periods available· newest 2008-12-31
Total assets: 9 of 11 periods available· newest 2008-12-31
Total liabilities: 5 of 11 periods available· newest 2008-12-31
Current assets: 9 of 11 periods available· newest 2008-12-31
Current liabilities: 8 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-20.7%

Prior period

USD 66,043

2007-01-01 – 2007-12-31
Current period

USD 52,348

2008-01-01 – 2008-12-31

Exact inputs and evidence

52348 − 66043 = -13695 USD

66043 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
52348 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CYTOGENIX INC · 2008-12-31 CYTOGENIX INC (edgar:1005302) Year-over-year change in Revenue: -13695 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 52348 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1633 Input fundies:Revenue: 66043 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1633
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.88 million

Prior period

−USD 6.27 million

2007-01-01 – 2007-12-31
Current period

−USD 3.39 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-3388623 − -6266075 = 2877452 USD

-6266075 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-3388623 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CYTOGENIX INC · 2008-12-31 CYTOGENIX INC (edgar:1005302) Year-over-year change in Net income: 2877452 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3388623 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1739 Input fundies:NetIncome: -6266075 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1739
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 39,290

2007-01-01 – 2007-12-31
Current period

USD 0

2008-01-01 – 2008-12-31

Exact inputs and evidence

0 − 39290 = -39290 USD

39290 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
0 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CYTOGENIX INC · 2008-12-31 CYTOGENIX INC (edgar:1005302) Year-over-year change in Capital expenditure: -39290 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1763 Input fundies:CapitalExpenditure: 39290 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1763
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 52,348 100% of revenue
Operating costs Derived USD 3.39 million 6,478% of revenue
Operating income −USD 3.34 million −6,378% of revenue
Tax, interest and other Derived USD 49,784 95% of revenue
Net income −USD 3.39 million −6,473% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure USD 0 0% of revenue
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Operating loss: operating costs were 476,034% of revenue.
2002 Operating loss: operating costs were 142,994% of revenue.
2003 Operating loss: operating costs were 2,985% of revenue.
2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2006 Operating loss: operating costs were 11,014% of revenue.
2007 Operating loss: operating costs were 9,605% of revenue.
2008 Operating loss: operating costs were 6,478% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	875	4165298 Derived	-4164423	0 Derived	-4164423	Unavailable	Source 2001-01-01 – 2001-12-31: 875 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -4164423 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -4164423 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -1268270 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	1700	2430904 Derived	-2429204	0 Derived	-2429204	-1616731 Derived	Source 2002-01-01 – 2002-12-31: 1700 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -2429204 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -2429204 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -1606344 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 10387 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	80000	2387663 Derived	-2307663	9562 Derived	-2317225	-1303387 Derived	Source 2003-01-01 – 2003-12-31: 80000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -2307663 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -2317225 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -1258029 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 45358 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	0	2365416 Derived	-2365416	-40 Derived	-2365376	-1682757 Derived	Source 2004-01-01 – 2004-12-31: 0 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -2365416 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -2365376 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -1669793 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 12964 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	0	3535162 Derived	-3535162	-2037 Derived	-3533125	-2614850 Derived	Source 2005-01-01 – 2005-12-31: 0 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -3535162 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -3533125 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -2597863 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 16987 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	76993	8480293 Derived	-8403300	-1389 Derived	-8401911	-4312930 Derived	Source 2006-01-01 – 2006-12-31: 76993 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -8403300 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -8401911 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -4058084 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 254846 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	66043	6343389 Derived	-6277346	-11271 Derived	-6266075	Unavailable	Source 2007-01-01 – 2007-12-31: 66043 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -6277346 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -6266075 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 39290 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	52348	3391187 Derived	-3338839	49784 Derived	-3388623	Unavailable	Source 2008-01-01 – 2008-12-31: 52348 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -3338839 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -3388623 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 52.3K 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Revenue	881	Revenue: 881 Open source
20012001-12-31	Revenue	875	Revenue: 875 Open source
20022002-12-31	Revenue	1700	Revenue: 1700 Open source
20032003-12-31	Revenue	80000	Revenue: 80000 Open source
20042004-12-31	Revenue	0	Revenue: 0 Open source
20052005-12-31	Revenue	0	Revenue: 0 Open source
20062006-12-31	Revenue	76993	Revenue: 76993 Open source
20072007-12-31	Revenue	66043	Revenue: 66043 Open source
20082008-12-31	Revenue	52348	Revenue: 52348 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-20.7% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Year over year	No prior comparable period	Revenue: 881 Open source
20012001-12-31	Year over year	-0.7%	Revenue: 875 Open source Revenue: 881 Open source
20022002-12-31	Year over year	94.3%	Revenue: 1700 Open source Revenue: 875 Open source
20032003-12-31	Year over year	4,605.9%	Revenue: 80000 Open source Revenue: 1700 Open source
20042004-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 80000 Open source
20052005-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20062006-12-31	Year over year	No prior comparable period	Revenue: 76993 Open source Revenue: 0 Open source
20072007-12-31	Year over year	-14.2%	Revenue: 66043 Open source Revenue: 76993 Open source
20082008-12-31	Year over year	-20.7%	Revenue: 52348 Open source Revenue: 66043 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -6,378.2% 2008

Net margin -6,473.3% 2008

Free cash flow margin -5,601.7% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2000-12-31	Operating margin	Not reported	Revenue: 881 Open source
20012001-12-31	Operating margin	-475,934.1%	Operating Income: -4164423 Open source Revenue: 875 Open source
20022002-12-31	Operating margin	-142,894.4%	Operating Income: -2429204 Open source Revenue: 1700 Open source
20032003-12-31	Operating margin	-2,884.6%	Operating Income: -2307663 Open source Revenue: 80000 Open source
20042004-12-31	Operating margin	Not reported	Operating Income: -2365416 Open source Revenue: 0 Open source
20052005-12-31	Operating margin	Not reported	Operating Income: -3535162 Open source Revenue: 0 Open source
20062006-12-31	Operating margin	-10,914.4%	Operating Income: -8403300 Open source Revenue: 76993 Open source
20072007-12-31	Operating margin	-9,504.9%	Operating Income: -6277346 Open source Revenue: 66043 Open source
20082008-12-31	Operating margin	-6,378.2%	Operating Income: -3338839 Open source Revenue: 52348 Open source
20002000-12-31	Net margin	-229,240.1%	Net Income: -2019605 Open source Revenue: 881 Open source
20012001-12-31	Net margin	-475,934.1%	Net Income: -4164423 Open source Revenue: 875 Open source
20022002-12-31	Net margin	-142,894.4%	Net Income: -2429204 Open source Revenue: 1700 Open source
20032003-12-31	Net margin	-2,896.5%	Net Income: -2317225 Open source Revenue: 80000 Open source
20042004-12-31	Net margin	Not reported	Net Income: -2365376 Open source Revenue: 0 Open source
20052005-12-31	Net margin	Not reported	Net Income: -3533125 Open source Revenue: 0 Open source
20062006-12-31	Net margin	-10,912.6%	Net Income: -8401911 Open source Revenue: 76993 Open source
20072007-12-31	Net margin	-9,487.9%	Net Income: -6266075 Open source Revenue: 66043 Open source
20082008-12-31	Net margin	-6,473.3%	Net Income: -3388623 Open source Revenue: 52348 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 881 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 875 Open source Operating Cash Flow: -1268270 Open source
20022002-12-31	Free cash flow margin	-95,101.8%	Revenue: 1700 Open source Operating Cash Flow: -1606344 Open source Capital Expenditure: 10387 Open source
20032003-12-31	Free cash flow margin	-1,629.2%	Revenue: 80000 Open source Operating Cash Flow: -1258029 Open source Capital Expenditure: 45358 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1669793 Open source Capital Expenditure: 12964 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2597863 Open source Capital Expenditure: 16987 Open source
20062006-12-31	Free cash flow margin	-5,601.7%	Revenue: 76993 Open source Operating Cash Flow: -4058084 Open source Capital Expenditure: 254846 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 66043 Open source Capital Expenditure: 39290 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 52348 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4.1M 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Operating cash flow	Not reported	No source recorded
20012001-12-31	Operating cash flow	-1268270	Operating Cash Flow: -1268270 Open source
20022002-12-31	Operating cash flow	-1606344	Operating Cash Flow: -1606344 Open source
20032003-12-31	Operating cash flow	-1258029	Operating Cash Flow: -1258029 Open source
20042004-12-31	Operating cash flow	-1669793	Operating Cash Flow: -1669793 Open source
20052005-12-31	Operating cash flow	-2597863	Operating Cash Flow: -2597863 Open source
20062006-12-31	Operating cash flow	-4058084	Operating Cash Flow: -4058084 Open source
20072007-12-31	Operating cash flow	Not reported	No source recorded
20082008-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -4.3M 2006

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Free cash flow	Unavailable	No source recorded
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1268270 Open source
20022002-12-31	Free cash flow	-1616731	Operating Cash Flow: -1606344 Open source Capital Expenditure: 10387 Open source
20032003-12-31	Free cash flow	-1303387	Operating Cash Flow: -1258029 Open source Capital Expenditure: 45358 Open source
20042004-12-31	Free cash flow	-1682757	Operating Cash Flow: -1669793 Open source Capital Expenditure: 12964 Open source
20052005-12-31	Free cash flow	-2614850	Operating Cash Flow: -2597863 Open source Capital Expenditure: 16987 Open source
20062006-12-31	Free cash flow	-4312930	Operating Cash Flow: -4058084 Open source Capital Expenditure: 254846 Open source
20072007-12-31	Free cash flow	Unavailable	Capital Expenditure: 39290 Open source
20082008-12-31	Free cash flow	Unavailable	Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

886.2% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2000-12-31	Liabilities / assets	Not reported	Total Assets: 530222 Open source
20012001-12-31	Liabilities / assets	62.4%	Total Liabilities: 899814 Open source Total Assets: 1441127 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 101329 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 353958 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 524693 Open source
20052005-12-31	Liabilities / assets	73%	Total Liabilities: 1102427 Open source Total Assets: 1509948 Open source
20062006-12-31	Liabilities / assets	31.1%	Total Liabilities: 1307931 Open source Total Assets: 4209684 Open source
20072007-12-31	Liabilities / assets	260.2%	Total Liabilities: 1965821 Open source Total Assets: 755633 Open source
20082008-12-31	Liabilities / assets	886.2%	Total Liabilities: 3383516 Open source Total Assets: 381782 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.06× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Current assets / current liabilities	0×	Current Assets: 1188 Open source Current Liabilities: 505811 Open source
20012001-12-31	Current assets / current liabilities	Not reported	Current Assets: 972111 Open source
20022002-12-31	Current assets / current liabilities	0.01×	Current Assets: 8214 Open source Current Liabilities: 666755 Open source
20032003-12-31	Current assets / current liabilities	0.43×	Current Assets: 257336 Open source Current Liabilities: 597202 Open source
20042004-12-31	Current assets / current liabilities	0.44×	Current Assets: 453235 Open source Current Liabilities: 1039753 Open source
20052005-12-31	Current assets / current liabilities	1.21×	Current Assets: 1329357 Open source Current Liabilities: 1102427 Open source
20062006-12-31	Current assets / current liabilities	2.61×	Current Assets: 3293028 Open source Current Liabilities: 1262916 Open source
20072007-12-31	Current assets / current liabilities	0.24×	Current Assets: 458478 Open source Current Liabilities: 1948485 Open source
20082008-12-31	Current assets / current liabilities	0.06×	Current Assets: 199577 Open source Current Liabilities: 3383516 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 4.16 million Exact value Exact value: -4164423 USD 2001-01-01 – 2001-12-31: -4164423 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2001-12-31 CYTOGENIX INC (edgar:1005302) Net Income: -4164423 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4164423 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-03-000047.txt#1572 The citation records this snapshot. The page link may show a newer release later.	−USD 1.27 million Exact value Exact value: -1268270 USD 2001-01-01 – 2001-12-31: -1268270 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGENIX INC · 2001-12-31 CYTOGENIX INC (edgar:1005302) Operating Cash Flow: -1268270 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1268270 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-03-000047.txt#1584 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 2.43 million Exact value Exact value: -2429204 USD 2002-01-01 – 2002-12-31: -2429204 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2002-12-31 CYTOGENIX INC (edgar:1005302) Net Income: -2429204 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2429204 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000106.txt#1637 The citation records this snapshot. The page link may show a newer release later.	−USD 1.61 million Exact value Exact value: -1606344 USD 2002-01-01 – 2002-12-31: -1606344 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGENIX INC · 2002-12-31 CYTOGENIX INC (edgar:1005302) Operating Cash Flow: -1606344 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1606344 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000106.txt#1651 The citation records this snapshot. The page link may show a newer release later.	USD 10,387 Exact value Exact value: 10387 USD 2002-01-01 – 2002-12-31: 10387 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGENIX INC · 2002-12-31 CYTOGENIX INC (edgar:1005302) Capital Expenditure: 10387 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10387 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000106.txt#1655 The citation records this snapshot. The page link may show a newer release later.	−USD 1.62 million Calculation and evidence -1606344 − 10387 USD Exact free cash flow: -1616731 USD 2002-01-01 – 2002-12-31: -1606344 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 10387 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGENIX INC · 2002-12-31 CYTOGENIX INC (edgar:1005302) Free cash flow: -1616731 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1606344 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000106.txt#1651 Input fundies:CapitalExpenditure: 10387 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000106.txt#1655 The citation records this snapshot. The page link may show a newer release later.
2003 2002-07-01 – 2003-06-30	−USD 743,210 Exact value Exact value: -743210 USD 2002-07-01 – 2003-06-30: -743210 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2003-06-30 CYTOGENIX INC (edgar:1005302) Net Income: -743210 USD Concept: fundies:NetIncome Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:NetIncome: -743210 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#247 The citation records this snapshot. The page link may show a newer release later.	−USD 386,730 Exact value Exact value: -386730 USD 2002-07-01 – 2003-06-30: -386730 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGENIX INC · 2003-06-30 CYTOGENIX INC (edgar:1005302) Operating Cash Flow: -386730 USD Concept: fundies:OperatingCashFlow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3AOperatingCashFlow&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -386730 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#261 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2002-07-01 – 2003-06-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGENIX INC · 2003-06-30 CYTOGENIX INC (edgar:1005302) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ACapitalExpenditure&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#265 The citation records this snapshot. The page link may show a newer release later.	−USD 386,730 Calculation and evidence -386730 − 0 USD Exact free cash flow: -386730 USD 2002-07-01 – 2003-06-30: -386730 USD · Inspect Operating Cash Flow · Source 2002-07-01 – 2003-06-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGENIX INC · 2003-06-30 CYTOGENIX INC (edgar:1005302) Free cash flow: -386730 USD Concept: free-cash-flow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -386730 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#261 Input fundies:CapitalExpenditure: 0 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#265 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 2.32 million Exact value Exact value: -2317225 USD 2003-01-01 – 2003-12-31: -2317225 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2003-12-31 CYTOGENIX INC (edgar:1005302) Net Income: -2317225 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2317225 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-06-000076.txt#2258 The citation records this snapshot. The page link may show a newer release later.	−USD 1.26 million Exact value Exact value: -1258029 USD 2003-01-01 – 2003-12-31: -1258029 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGENIX INC · 2003-12-31 CYTOGENIX INC (edgar:1005302) Operating Cash Flow: -1258029 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1258029 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-06-000076.txt#2273 The citation records this snapshot. The page link may show a newer release later.	USD 45,358 Exact value Exact value: 45358 USD 2003-01-01 – 2003-12-31: 45358 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGENIX INC · 2003-12-31 CYTOGENIX INC (edgar:1005302) Capital Expenditure: 45358 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 45358 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-06-000076.txt#2277 The citation records this snapshot. The page link may show a newer release later.	−USD 1.3 million Calculation and evidence -1258029 − 45358 USD Exact free cash flow: -1303387 USD 2003-01-01 – 2003-12-31: -1258029 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 45358 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGENIX INC · 2003-12-31 CYTOGENIX INC (edgar:1005302) Free cash flow: -1303387 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1258029 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-06-000076.txt#2273 Input fundies:CapitalExpenditure: 45358 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-06-000076.txt#2277 The citation records this snapshot. The page link may show a newer release later.
2004 2003-07-01 – 2004-06-30	−USD 844,375 Exact value Exact value: -844375 USD 2003-07-01 – 2004-06-30: -844375 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2004-06-30 CYTOGENIX INC (edgar:1005302) Net Income: -844375 USD Concept: fundies:NetIncome Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:NetIncome: -844375 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#247 The citation records this snapshot. The page link may show a newer release later.	−USD 824,910 Exact value Exact value: -824910 USD 2003-07-01 – 2004-06-30: -824910 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGENIX INC · 2004-06-30 CYTOGENIX INC (edgar:1005302) Operating Cash Flow: -824910 USD Concept: fundies:OperatingCashFlow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3AOperatingCashFlow&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -824910 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#261 The citation records this snapshot. The page link may show a newer release later.	USD 7,330 Exact value Exact value: 7330 USD 2003-07-01 – 2004-06-30: 7330 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGENIX INC · 2004-06-30 CYTOGENIX INC (edgar:1005302) Capital Expenditure: 7330 USD Concept: fundies:CapitalExpenditure Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ACapitalExpenditure&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7330 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#265 The citation records this snapshot. The page link may show a newer release later.	−USD 832,240 Calculation and evidence -824910 − 7330 USD Exact free cash flow: -832240 USD 2003-07-01 – 2004-06-30: -824910 USD · Inspect Operating Cash Flow · Source 2003-07-01 – 2004-06-30: 7330 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGENIX INC · 2004-06-30 CYTOGENIX INC (edgar:1005302) Free cash flow: -832240 USD Concept: free-cash-flow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -824910 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#261 Input fundies:CapitalExpenditure: 7330 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-04-000226.txt#265 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 2.37 million Exact value Exact value: -2365376 USD 2004-01-01 – 2004-12-31: -2365376 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2004-12-31 CYTOGENIX INC (edgar:1005302) Net Income: -2365376 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2365376 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000157.txt#6093 The citation records this snapshot. The page link may show a newer release later.	−USD 1.67 million Exact value Exact value: -1669793 USD 2004-01-01 – 2004-12-31: -1669793 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGENIX INC · 2004-12-31 CYTOGENIX INC (edgar:1005302) Operating Cash Flow: -1669793 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1669793 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000157.txt#6418 The citation records this snapshot. The page link may show a newer release later.	USD 12,964 Exact value Exact value: 12964 USD 2004-01-01 – 2004-12-31: 12964 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGENIX INC · 2004-12-31 CYTOGENIX INC (edgar:1005302) Capital Expenditure: 12964 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12964 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000157.txt#6468 The citation records this snapshot. The page link may show a newer release later.	−USD 1.68 million Calculation and evidence -1669793 − 12964 USD Exact free cash flow: -1682757 USD 2004-01-01 – 2004-12-31: -1669793 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 12964 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGENIX INC · 2004-12-31 CYTOGENIX INC (edgar:1005302) Free cash flow: -1682757 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1669793 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000157.txt#6418 Input fundies:CapitalExpenditure: 12964 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000157.txt#6468 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 3.53 million Exact value Exact value: -3533125 USD 2005-01-01 – 2005-12-31: -3533125 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2005-12-31 CYTOGENIX INC (edgar:1005302) Net Income: -3533125 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3533125 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000178.txt#6503 The citation records this snapshot. The page link may show a newer release later.	−USD 2.6 million Exact value Exact value: -2597863 USD 2005-01-01 – 2005-12-31: -2597863 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGENIX INC · 2005-12-31 CYTOGENIX INC (edgar:1005302) Operating Cash Flow: -2597863 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2597863 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000157.txt#6418 The citation records this snapshot. The page link may show a newer release later.	USD 16,987 Exact value Exact value: 16987 USD 2005-01-01 – 2005-12-31: 16987 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGENIX INC · 2005-12-31 CYTOGENIX INC (edgar:1005302) Capital Expenditure: 16987 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16987 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000178.txt#7075 The citation records this snapshot. The page link may show a newer release later.	−USD 2.61 million Calculation and evidence -2597863 − 16987 USD Exact free cash flow: -2614850 USD 2005-01-01 – 2005-12-31: -2597863 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 16987 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGENIX INC · 2005-12-31 CYTOGENIX INC (edgar:1005302) Free cash flow: -2614850 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2597863 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000157.txt#6418 Input fundies:CapitalExpenditure: 16987 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000178.txt#7075 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 8.4 million Exact value Exact value: -8401911 USD 2006-01-01 – 2006-12-31: -8401911 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2006-12-31 CYTOGENIX INC (edgar:1005302) Net Income: -8401911 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8401911 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000178.txt#6503 The citation records this snapshot. The page link may show a newer release later.	−USD 4.06 million Exact value Exact value: -4058084 USD 2006-01-01 – 2006-12-31: -4058084 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGENIX INC · 2006-12-31 CYTOGENIX INC (edgar:1005302) Operating Cash Flow: -4058084 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4058084 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000157.txt#6418 The citation records this snapshot. The page link may show a newer release later.	USD 254,846 Exact value Exact value: 254846 USD 2006-01-01 – 2006-12-31: 254846 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGENIX INC · 2006-12-31 CYTOGENIX INC (edgar:1005302) Capital Expenditure: 254846 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 254846 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000178.txt#7075 The citation records this snapshot. The page link may show a newer release later.	−USD 4.31 million Calculation and evidence -4058084 − 254846 USD Exact free cash flow: -4312930 USD 2006-01-01 – 2006-12-31: -4058084 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 254846 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGENIX INC · 2006-12-31 CYTOGENIX INC (edgar:1005302) Free cash flow: -4312930 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4058084 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000157.txt#6418 Input fundies:CapitalExpenditure: 254846 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001121781-08-000178.txt#7075 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 6.27 million Exact value Exact value: -6266075 USD 2007-01-01 – 2007-12-31: -6266075 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2007-12-31 CYTOGENIX INC (edgar:1005302) Net Income: -6266075 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6266075 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1739 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 39,290 Exact value Exact value: 39290 USD 2007-01-01 – 2007-12-31: 39290 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGENIX INC · 2007-12-31 CYTOGENIX INC (edgar:1005302) Capital Expenditure: 39290 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 39290 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1763 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 3.39 million Exact value Exact value: -3388623 USD 2008-01-01 – 2008-12-31: -3388623 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGENIX INC · 2008-12-31 CYTOGENIX INC (edgar:1005302) Net Income: -3388623 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3388623 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1739 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 0 Exact value Exact value: 0 USD 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGENIX INC · 2008-12-31 CYTOGENIX INC (edgar:1005302) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1005302/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1005302/0001010549-09-000373.txt#1763 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

50 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001005302, 1005302, edgar:1005302

Also known as CRYOGENIC SOLUTIONS INC

CYTOGENIX INC

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation